Latest FDA Stories
CE Class Focuses on Fundamentals of Biosimilars EAST ELMHURST, N.Y., March 16, 2015 /PRNewswire/ -- With the U.S.
Coral Springs, FLORIDA, March 16, 2015 /PRNewswire/ -- The global market for fish oil omega-3 is projected to grow from $1.1 billion in 2011 to $1.7 billion by 2018.
Management Projecting $2.5 Million in Year over Year Sales Toronto, ON, March 16, 2015 /PRNewswire/ -- Axxess Pharma Inc.
NEW YORK, March 16, 2015 /PRNewswire/ --Kalorama information suggests that the FDA approval of a rare gene test from Mountain View, Calif.-based personal genetics company 23andMe will open the
The Onder Law Firm has updated its website to provide timely morcellator lawsuit news at MorcellatorCancerLawsuitCenter.com. St.
Diet Doc has earned their reputation of trust, safety and reliability by providing safe and natural prescription diet pills, all accompanied by a complete disclosure of active ingredients when
The San Diego injury law firm discusses birth defect allegations associated with Zofran use, as two recently filed lawsuits allege that Zofran manufacturer GlaxoSmithKline failed to inform doctors
- First atypical antipsychotic to be approved for pediatric patients with bipolar I disorder in the last five years - DUBLIN, March 13, 2015 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced
The FDA requires drug and device makers to conduct regular effectiveness checks on their recall processes.
Devicemakers must take steps now to secure a production account for submitting electronic Medical Device Reports (eMDRs), ahead of an Aug. 14, 2015 deadline for compliance.
- Large; stout; burly.